Loading clinical trials...
Loading clinical trials...
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sumitomo Pharma America, Inc.
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT06370988 · Bipolar Depression, Bipolar Disorder, and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT06524505 · Bipolar Depression
NCT06599099 · Bipolar Depression
Synergy Escondido,710 East Grand Ave.
Escondido, California
Collaborative Neuroscience Network Inc.,12772 Valley View Street,Suite 3
Garden Grove, California
Excell Research, Inc,3998 Vista Way,Suite 100
Oceanside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions